Company news

Wockhardt Limited news in 2026

Wockhardt Limited's news releases, calls and decks from 2026, newest first.

View company

Wockhardt Limited has informed the Exchange regarding a press release dated November 02, 2026, titled "Pursuant to Regulation 30 of the Listing Regulations, please find enclosed Press Release on the Un-audited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2026.".

November 2, 2026

Wockhardt Limited Press Release Aug 10 2026

August 10, 2026

Wockhardt Receives U.S. FDA Approval for ZAYNICH™ (cefepime and zidebactam), a Novel Intravenous Antibiotic for the Treatment of Adult Patients with Complicated Urinary Tract Infection Including Pyelonephritis

June 1, 2026

Press Release May 30 2026

May 30, 2026

Press Release May 28 2026

May 27, 2026

Press Release May 04 2026

May 4, 2026

Press Release Mar 30 2026

March 30, 2026

Wockhardt Limited Press Release Mar 30 2026

March 29, 2026

Press Release Feb 10 2026

February 10, 2026

Press Release Jan 27 2026

January 27, 2026

Wockhardt Limited Press Release Jan 27 2026

January 26, 2026

Press Release Jan 07 2026

January 7, 2026

Wockhardt Limited Press Release Jan 07 2026

January 6, 2026

Decks in 2026